Goldschmidt, Hartmut
Ashcroft, John
Szabo, Zsolt
Garderet, Laurent
Funding for this research was provided by:
Amgen (Europe) GmbH
Article History
Received: 23 November 2017
Accepted: 6 November 2018
First Online: 23 November 2018
Compliance with ethical standards
:
: HG has received research support from Bristol-Myers Squibb, Celgene Ltd., Chugai, Janssen, Millenium Pharmaceuticals, Inc., and Novartis International AG, has participated in advisory boards for Amgen, Bristol-Myers Squibb, Celgene Ltd., Janssen, Novartis International AG, Onyx Pharmaceuticals, Inc., and Takeda, and has received honoraria from Celgene Ltd., Chugai, Janssen, Millenium Pharmaceuticals, Inc., Novartis International AG, and Onyx Pharmaceuticals, Inc. JA has participated in advisory boards and as a consultant for Amgen, Celgene Ltd., Janssen, and Takeda. ZS is an employee of Amgen and holds stock. LG is a consultant for Amgen, Novartis International AG, and Takeda.